11803 related articles for article (PubMed ID: 12168844)
1. Anti-proliferative and antitumoral activities of a functionalized dextran (CMDBJ) on the 1205 L-U human tumor melanoma cells.
Bastias J; Wei MX; Huynh R; Chaubet F; Jozefonvicz J; Crepin M
Anticancer Res; 2002; 22(3):1603-13. PubMed ID: 12168844
[TBL] [Abstract][Full Text] [Related]
2. Aponecrotic, antiangiogenic and antiproliferative effects of a novel dextran derivative on breast cancer growth in vitro and in vivo.
Di Benedetto M; Starzec A; Colombo BM; Briane D; Perret GY; Kraemer M; Crépin M
Br J Pharmacol; 2002 Apr; 135(8):1859-71. PubMed ID: 11959788
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
Bandyopadhyay A; López-Casillas F; Malik SN; Montiel JL; Mendoza V; Yang J; Sun LZ
Cancer Res; 2002 Aug; 62(16):4690-5. PubMed ID: 12183427
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
5. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).
Bagheri-Yarmand R; Kourbali Y; Mabilat C; Morère JF; Martin A; Lu H; Soria C; Jozefonvicz J; Crépin M
Br J Cancer; 1998 Jul; 78(1):111-8. PubMed ID: 9662260
[TBL] [Abstract][Full Text] [Related]
6. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
7. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
[TBL] [Abstract][Full Text] [Related]
8. Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice.
Di Benedetto M; Kourbali Y; Starzec A; Vassy R; Jozefonvicz J; Perret G; Crepin M; Kraemer M
Br J Cancer; 2001 Sep; 85(6):917-23. PubMed ID: 11556846
[TBL] [Abstract][Full Text] [Related]
9. [Studies on antitumor activity of rhEndostatin].
Li HY; Li Y; Liu ZH; Wu HJ; Chen FH; Chen XG
Yao Xue Xue Bao; 2002 Oct; 37(10):763-6. PubMed ID: 12567857
[TBL] [Abstract][Full Text] [Related]
10. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.
Bagheri-Yarmand R; Kourbali Y; Morère JF; Jozefonvicz J; Crépin M
Cell Growth Differ; 1998 Jun; 9(6):497-504. PubMed ID: 9663468
[TBL] [Abstract][Full Text] [Related]
12. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic and antitumor activity of IDN 5390, a new taxane derivative.
Taraboletti G; Micheletti G; Rieppi M; Poli M; Turatto M; Rossi C; Borsotti P; Roccabianca P; Scanziani E; Nicoletti MI; Bombardelli E; Morazzoni P; Riva A; Giavazzi R
Clin Cancer Res; 2002 Apr; 8(4):1182-8. PubMed ID: 11948131
[TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of human melanoma tumor cells by the combination of sodium phenylacetate (NaPA) and substituted dextrans and one NaPA-dextran conjugate.
Gervelas C; Avramoglou T; Crépin M; Jozefonvicz J
Anticancer Drugs; 2002 Jan; 13(1):37-45. PubMed ID: 11914639
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
16. Effect of U-995, a potent shark cartilage-derived angiogenesis inhibitor, on anti-angiogenesis and anti-tumor activities.
Sheu JR; Fu CC; Tsai ML; Chung WJ
Anticancer Res; 1998; 18(6A):4435-41. PubMed ID: 9891506
[TBL] [Abstract][Full Text] [Related]
17. Carboxymethyl benzylamide dextran blocks angiogenesis of MDA-MB435 breast carcinoma xenografted in fat pad and its lung metastases in nude mice.
Bagheri-Yarmand R; Kourbali Y; Rath AM; Vassy R; Martin A; Jozefonvicz J; Soria C; Lu H; Crépin M
Cancer Res; 1999 Feb; 59(3):507-10. PubMed ID: 9973189
[TBL] [Abstract][Full Text] [Related]
18. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo.
Ma JG; Huang H; Chen SM; Chen Y; Xin XL; Lin LP; Ding J; Liu H; Meng LH
Breast Cancer Res Treat; 2011 Nov; 130(1):85-96. PubMed ID: 21181437
[TBL] [Abstract][Full Text] [Related]
19. In vitro stimulation of human endothelial cells by derivatized dextrans.
Letourneur D; Champion J; Slaoui F; Jozefonvicz J
In Vitro Cell Dev Biol; 1993 Jan; 29A(1):67-72. PubMed ID: 7680338
[TBL] [Abstract][Full Text] [Related]
20. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
